How to Help Your Patients Find Indomethacin in Stock: A Provider's Guide

When patients call your office saying they can't fill their indomethacin prescription, it puts your care team in a difficult position — especially when the patient is in the middle of a gout flare or an arthritis exacerbation. This guide gives you a practical framework for responding to indomethacin access issues, from immediate steps to longer-term prescribing adjustments.

Understanding the Current Indomethacin Supply Picture

Standard indomethacin 25 mg and 50 mg capsules are generally in supply from multiple generic manufacturers in 2026. The 75 mg extended-release formulation is more vulnerable, having been subject to two manufacturer recalls in 2024 and 2025 (Glenmark and KVK-Tech). Specialty forms — oral suspension and rectal suppository — have near-absent commercial availability, requiring compounding or specialty pharmacy access.

For most patients, the challenge isn't a true drug shortage but rather their particular pharmacy being out of stock. In these cases, patient navigation — helping them find a pharmacy that has it — is the fastest solution.

Step 1: Triage the Patient's Situation

When a patient reports they can't fill indomethacin, determine:

Which formulation are they trying to fill? (25 mg IR, 50 mg IR, 75 mg ER, or other)

Have they tried only one pharmacy, or multiple?

Is this an acute situation (active gout flare) or maintenance therapy?

Does the patient have contraindications or intolerance to other NSAIDs?

A patient in an active acute gout attack who can't get indomethacin needs a faster resolution than someone on maintenance therapy who has a week's supply left.

Step 2: Direct Patients to a Pharmacy Search Tool

Rather than having your staff call pharmacies, direct patients to medfinder — a service that calls pharmacies near the patient to check which ones have the specific medication and formulation in stock. This offloads the search work from both your staff and the patient, and results are delivered by text. This is especially valuable for patients with mobility issues or those who can't be on hold with multiple pharmacies while experiencing pain.

Step 3: Consider a Formulation Bridge

If the 75 mg ER formulation is unavailable but the patient tolerates indomethacin well, consider bridging with immediate-release capsules. Approximate equivalents:

75 mg ER once daily ≈ 25 mg IR three times daily (with food)

75 mg ER once daily ≈ 50 mg IR twice daily (if 50 mg BID is clinically appropriate for the indication)

Counsel patients that IR formulations may cause more GI side effects than ER due to higher peak plasma concentrations. Taking IR indomethacin with food or milk reduces gastric irritation.

39,333+ patients found their medications in stock

39K+

Find Indomethacin In Stock Today →

Step 4: Issue a Therapeutic Alternative Prescription

If indomethacin is genuinely unavailable in your area or the patient needs an immediate solution, here are preferred therapeutic alternatives by indication:

Acute gout: Naproxen 500 mg BID x 5-7 days (with food), or colchicine 1.2 mg then 0.6 mg one hour later; low-dose protocol has fewer GI effects

Osteoarthritis / chronic pain: Meloxicam 15 mg once daily or celecoxib 200 mg once daily

Rheumatoid arthritis: Naproxen 250-500 mg BID or celecoxib 100-200 mg BID; coordinate with rheumatology for DMARD optimization

Ankylosing spondylitis: Naproxen 500 mg BID or diclofenac 50 mg BID-TID; full-dose NSAIDs continuously shown to slow radiographic progression in AS

Bursitis/tendinitis: Ibuprofen 400-800 mg TID-QID (with food) or naproxen 250-500 mg BID

Step 5: Consider Compounding for Specialty Forms

For patients who specifically require the indomethacin oral suspension (e.g., pediatric patients with juvenile arthritis or patients unable to swallow capsules) or the rectal suppository, commercial supply is effectively absent. Accredited 503A compounding pharmacies can prepare custom indomethacin formulations from pharmaceutical-grade API. Referrals to specialty compounding pharmacies may be necessary for these patients.

Skip the calls, skip the stress.

Find Indomethacin In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Proactive Prescribing Strategies

For patients on long-term indomethacin therapy, consider these proactive strategies to minimize future disruption:

Write prescriptions for 90-day supplies through mail-order pharmacies when appropriate

For 75 mg ER patients: have an IR contingency prescription on file

Reassess elderly patients on indomethacin — Beers Criteria concerns make a supply disruption an opportunity to optimize to a better-tolerated agent

For indomethacin-responsive headache patients, maintain a relationship with a compounding pharmacy as backup

For a full clinical overview of the shortage, formulation availability, and alternative protocols by indication, see our companion article: Indomethacin Shortage 2026: What Providers Need to Know.